MAPT and Alzheimer disease: The structural requirements for multisite AChE inhibitorsimposedby the AChE gorge shape a particular type of molecule that can inherentlymodulate other key targets in AD, such as BACE-1 and β-amyloid(Aβ) and tau aggregation.